Schizophrenic: Forever young?

Genome Medicine

Volumn 2, Issue 5, 2010, Pages

  Baldi, Benedetta Frida ^a   Hoyer, Christine ^a   Le Novère, Nicolas ^a  

^a EUROPEAN BIOINFORMATICS INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COPY NUMBER VARIATION; DISEASE COURSE; DOWN REGULATION; GENE CONTROL; GENE FUNCTION; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENOMICS; GRAY MATTER; HUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 78751696858     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm153     Document Type: Review

References (28)

1. Goldner EM, Hsu L, Waraich P, Somers JM. Prevalence and incidence studies of schizophrenic disorders: a systematic review of the literature. Can J Psychiatry 2002, 47:833-843.
2. Mangalore R, Knapp M. Cost of schizophrenia in England. J Ment Health Policy Econ 2007, 10:23-41.
3. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders - Diagnostic Criteria for Research 1993, Geneva: World Health Organization, World Health Organization.
4. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2000, Washington, DC: American Psychiatric Association, American Psychiatric Association.
5. Schneider K. Clinical Psychopathology 1959, New York: Grune and Stratton, 5.
6. Seeman P. Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1987, 1:133-152. 10.1002/syn.890010203, 2905529.
7. Olney JW, Newcomer JW, Farber NB. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 1999, 33:523-533. 10.1016/S0022-3956(99)00029-1, 10628529.
8. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991, 148:1301-1308.
9. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB, Charney DS. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 1994, 51:199-214.
10. Karlsgodt KH, Sun D, Jimenez AM, Lutkenhoff ES, Willhite R, van Erp TGM, Cannon TD. Developmental disruptions in neural connectivity in the pathophysiology of schizophrenia. Dev Psychopathol 2008, 20:1297-1327. 10.1017/S095457940800062X, 18838043.
11. Sullivan PF, Kendler KS, Neale MC. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003, 60:1187-1192. 10.1001/archpsyc.60.12.1187, 14662550.
12. Brandon NJ, Millar JK, Korth C, Sive H, Singh KK, Sawa A. Understanding the role of DISC1 in psychiatric disease and during normal development. J Neurosci 2009, 29:12768-12775. 10.1523/JNEUROSCI.3355-09.2009, 19828788.
13. Badner JA, Gershon ES. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 2002, 7:405-411. 10.1038/sj.mp.4001012, 11986984.
14. Lewis CM, Levinson DF, Wise LH, DeLisi LE, Straub RE, Hovatta I, Williams NM, Schwab SG, Pulver AE, Faraone SV, Brzustowicz LM, Kaufmann CA, Garver DL, Gurling HMD, Lindholm E, Coon H, Moises HW, Byerley W, Shaw SH, Mesen A, Sherrington R, O'Neill FA, Walsh D, Kendler KS, Ekelund J, Paunio T, Loennqvist J, Peltonen L, O'Donovan MC, Owen MJ, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: schizophrenia. Am J Hum Genet 2003, 73:34-48. 10.1086/376549, 1180588, 12802786.
15. Shi J, Levinson DF, Duan J, Sanders AR, Zheng Y, Pe'er I, Dudbridge F, Holmans PA, Whittemore AS, Mowry BJ, Olincy A, Amin F, Cloninger CR, Silverman JM, Buccola NG, Byerley WF, Black DW, Crowe RR, Oksenberg JR, Mirel DB, Kendler KS, Freedman R, Gejman PV. Common variants on chromosome 6p22.1 are associated with schizophrenia. Nature 2009, 460:753-757. 2775422, 19571809.
16. Shifman S, Bronstein M, Sternfeld M, Pisant'e-Shalom A, Lev-Lehman E, Weizman A, Reznik I, Spivak B, Grisaru N, Karp L, Schiffer R, Kotler M, Strous RD, Swartz-Vanetik M, Knobler HY, Shinar E, Beckmann JS, Yakir B, Risch N, Zak NB, Darvasi A. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 2002, 71:1296-1302. 10.1086/344514, 378567, 12402217.
17. Mackie S, Millar JK, Porteous DJ. Role of DISC1 in neural development and schizophrenia. Curr Opin Neurobiol 2007, 17:95-102. 10.1016/j.conb.2007.01.007, 17258902.
18. Konradi C. Gene expression microarray studies in polygenic psychiatric disorders: applications and data analysis. Brain Res Brain Res Rev 2005, 50:142-155. 10.1016/j.brainresrev.2005.05.004, 15964635.
19. Martins-De-Souza D, Dias-Neto E, Schmitt A, Falkai P, Gormanns P, Maccarrone G, Turck CW, Gattaz WF. Proteome analysis of schizophrenia brain tissue. World J Biol Psychiatry 2010, 11:110-120. 10.3109/15622970903490626, 20109112.
20. Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG. Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev 2008, 60:358-403. 10.1124/pr.107.00107, 18922967.
21. Prabakaran S, Swatton JE, Ryan MM, Huffaker SJ, Huang JTJ, Griffin JL, Wayland M, Freeman T, Dudbridge F, Lilley KS, Karp NA, Hester S, Tkachev D, Mimmack ML, Yolken RH, Webster MJ, Torrey EF, Bahn S. Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress. Mol Psychiatry 2004, 9:684-97. 10.1038/sj.mp.4001532, 15098003.
22. Torkamani A, Dean B, Schork NJ, Thomas EA. Coexpression network analysis of neural tissue reveals perturbations in developmental processes in schizophrenia. Genome Res 2010, 20:403-412. 10.1101/gr.101956.109, 2847743, 20197298.
23. Margolin AA, Nemenman I, Basso K, Wiggins C, Stolovitzky G, Dalla Favera R, Califano A. ARACNE: an algorithm for the reconstruction of gene regulatory networks in a mammalian cellular context. BMC Bioinformatics 2006, 7(Suppl 1):S7. 10.1186/1471-2105-7-S1-S7, 1810318, 16723010.
24. Douaud G, Mackay C, Andersson J, James S, Quested D, Ray MK, Connell J, Roberts N, Crow TJ, Matthews PM, Smith S, James A. Schizophrenia delays and alters maturation of the brain in adolescence. Brain 2009, 132:2437-2448. 10.1093/brain/awp126, 19477963.
25. Jucaite A, Forssberg H, Karlsson P, Halldin C, Farde L. Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study. Neuroscience 2010, 167:104-110. 10.1016/j.neuroscience.2010.01.034, 20109534.
26. Wahlstrom D, White T, Luciana M. Neurobehavioral evidence for changes in dopamine system activity during adolescence. Neurosci Biobehav Rev 2010, 34:631-648. 10.1016/j.neubiorev.2009.12.007, 20026110.
27. Jaaro-Peled H, Hayashi-Takagi A, Seshadri S, Kamiya A, Brandon NJ, Sawa A. Neurodevelopmental mechanisms of schizophrenia: understanding disturbed postnatal brain maturation through neuregulin-1-ErbB4 and DISC1. Trends Neurosci 2009, 32:485-495. 10.1016/j.tins.2009.05.007, 2755075, 19712980.
28. Taylor CF, Field D, Sansone SA, Aerts J, Apweiler R, Ashburner M, Ball CA, Binz PA, Bogue M, Booth T, Brazma A, Brinkman RR, Michael Clark A, Deutsch EW, Fiehn O, Fostel J, Ghazal P, Gibson F, Gray T, Grimes G, Hancock JM, Hardy NW, Hermjakob H, Julian RK, Kane M, Kettner C, Kinsinger C, Kolker E, Kuiper M, Le Novère N, et al. Promoting coherent minimum reporting guidelines for biological and biomedical investigations: the MIBBI project. Nat Biotechnol 2008, 26:889-896. 10.1038/nbt.1411, 2771753, 18688244.